In addition, as ER stress and insulin misfolding are well established in their roles in β cell dysfunction and demise in type 2 diabetes, IRE1α inhibition may well be considered for the treatment of type 2 disease. The gene discussed is INS; the disease is type 2 diabetes mellitus.